Shelley K. Ballentine
Publications by Year
Research Areas
Cytokine Signaling Pathways and Interactions, Coagulation, Bradykinin, Polyphosphates, and Angioedema, HER2/EGFR in Cancer Research, Cytomegalovirus and herpesvirus research, Complement system in diseases
Most-Cited Works
- → JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemia(2009)107 cited
- → Design and Optimization of Benzimidazole-Containing Transient Receptor Potential Melastatin 8 (TRPM8) Antagonists(2010)65 cited
- → Discovery of novel FMS kinase inhibitors as anti-inflammatory agents(2008)51 cited
- → Acridone-Based Inhibitors of Inosine 5‘-Monophosphate Dehydrogenase: Discovery and SAR Leading to the Identification of N-(2-(6-(4-Ethylpiperazin-1-yl)pyridin-3-yl)propan-2-yl)-2- fluoro-9-oxo-9,10-dihydroacridine-3-carboxamide (BMS-566419)(2007)49 cited
- → Synthesis and evaluation of novel 3,4,6-substituted 2-quinolones as FMS kinase inhibitors(2008)47 cited
- → Discovery of vinylcycloalkyl-substituted benzimidazole TRPM8 antagonists effective in the treatment of cold allodynia(2012)40 cited
- → Novel indole-based inhibitors of IMPDH: introduction of hydrogen bond acceptors at indole C-3(2003)39 cited
- → 3-Cyanoindole-based inhibitors of inosine monophosphate dehydrogenase: synthesis and initial structure–Activity relationships(2003)34 cited
- → Discovery and Clinical Evaluation of 1-{N-[2-(Amidinoaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-[2,2-difluoro-2-phenylethylamino]pyrazinone (RWJ-671818), a Thrombin Inhibitor with an Oxyguanidine P1 Motif(2010)33 cited
- → Structure-based optimization of a potent class of arylamide FMS inhibitors(2008)32 cited